A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dicyclomine
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Propafenone.
Dicyclomine
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Propafenone.
Dicyclomine
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Propafenone.
Dicyclomine
Brompheniramine
The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Propafenone.
Dicyclomine
Rosoxacin
The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Propafenone.
Dicyclomine
Indapamide
The risk or severity of QTc prolongation can be increased when Indapamide is combined with Propafenone.
Dicyclomine
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Propafenone.
Dicyclomine
Clarithromycin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Clarithromycin.
Dicyclomine
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Levacetylmethadol.
Dicyclomine
Sultopride
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Sultopride.
Dicyclomine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Sitafloxacin.
Dicyclomine
Oxatomide
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Oxatomide.
Dicyclomine
Abexinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Abexinostat.
Dicyclomine
Mizolastine
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Mizolastine.
Dicyclomine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Ricolinostat.
Dicyclomine
CUDC-101
The risk or severity of QTc prolongation can be increased when Propafenone is combined with CUDC-101.
Dicyclomine
Entinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Entinostat.
Dicyclomine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Mocetinostat.
Dicyclomine
Amifampridine
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Amifampridine.
Dicyclomine
Butriptyline
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Butriptyline.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3